NT-34 COMPLETE RESPONSE TO VEMURAFINIB IN A PATIENT WITH METASTATIC ANAPLASTIC XANTHROASTROCYTOMA

INTRODUCTION: Approximately 70% of pleomorphic xanthroastrocytomas(PXA) harbor the BRAF-V600E mutation.Vemurafinib has demonstrated activity in melanoma patients with the mutation, but variable activity in other tumors. We report complete response to vemurafanib in a patient with metastatic, anaplas...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Thomas, Reena, Ajlan, Abdulrazag, Ziskin, Jennifer, Soltys, Scott, Reddy, Sunil, Recht, Lawrence, Nagpal, Seema
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218443/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou265.32
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi